A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization

American Journal of Gastroenterology

Volumn 93, Issue 5, 1998, Pages 743-747

  Levin, Theodore R ^a   Schmittdiel, Julie A ^b   Henning, James M ^b   Kunz, Kimberly ^b   Henke, Curtis J ^b   Colby, Chris J ^b   Selby, Joseph V ^b  

^a DIVISION OF RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIULCER AGENT; STOMACH SECRETION INHIBITOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HEALTH MAINTENANCE ORGANIZATION; HELICOBACTER PYLORI; HUMAN; MALE; OUTPATIENT CARE; PEPTIC ULCER; PRIORITY JOURNAL;

AMBULATORY CARE; COSTS AND COST ANALYSIS; DRUG COSTS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER;

EID: 0032081087     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.217_a.x     Document Type: Article

References (21)

1. 1. Sonnenberg A, Everhart JE. Health impact of peptic ulcer in the United States. Am J Gastroenterol 1997;92:614-20.
2. 2. Levin TR, Schmittdiel JA, Kunz K, et al. Cost of acid-related disorders to a large health maintenance organization. Gastroenterology 1997; 112:A26.
3. 3. Levin TR, Schmittdiel JA, Kunz K, et al. Costs of acid-related disorders to a health maintenance organization. Am J Med 1997;103: 520-8.
4. 4. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
5. 5. Soll AH. Medical treatment of peptic ulcer disease: Practice guidelines. JAMA 1996;275:622-9.
6. 6. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Int Med 1992; 116:705-8.
7. 7. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicilin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328: 308-12.
8. 8. Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Int Med 1995;123:260-8.
9. 9. Imperiale TF, Speroff T, Cebul R, et al. A cost analysis of alternative treatments for duodenal ulcer. Ann Int Med 1995;123:665-72.
10. 10. Taylor JL, Zagari M, Murphy K, et al. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. Arch Int Med 1997;157:87-97.
11. 11. Unge P, Jonsson B, Stalhammer N-O: The cost-effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden. Pharmacoeconomics 1995;8: 410-27.
12. 12. Vakil N, Fennerty MB: Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. Am J Gastroenterol 1996;91:239-45.
13. 13. Fendrick AM, Fennerty MB, Chey WD: Symptom status and the desire for H. pylori confirmatory testing after eradication treatment. Gastroenterology 1997;112:A14.
14. 14. Labenz J, Blum A, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
15. 15. Fennerty MB, Lieberman DL, Magaret N: Effectiveness of H. pylori treatment regimens in clinical practice: A community-based outcomes study. Gastroenterology 1997;112:A14.
16. 16. Sonnenberg A. Comparative cost-effectiveness of three ulcer therapies. Gastroenterology 1997;112:A43.
17. 17. Jensen GA, Morrisey MA, Gaffney S, et al. The new dominance of managed care: Insurance trends in the 1990s. Health Affairs 1997;16: 125-36.
18. 18. Cleary MI, Garrard J, Walters C, et al. Use of H. pylori eradication and subsequent expenditures in a large health plan. Gastroenterology 1997; 112:A10.
19. 19. Laine L, Peterson WL: Bleeding peptic ulcer. N Engl J Med 1994; 331:717-27.
20. 20. Davis CE. Generalizing from clinical trials. Control Clin Trial 1994; 15:11-4.
21. 21. Talley N. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994;106:1174-83.